UPDATE: GT Advanced Technologies' (GTATQ) Bankruptcy Judge Denies Request to Pay Critical Vendors Oct 21, 2014 12:26PM

(Updated - October 21, 2014 12:26 PM EDT)

GT Advanced Technologies (NASDAQ: GTAT) (OTCBB: GTATQ) judge denies request to pay critical vendors, according to Bloomberg headlines.

UPDATE - U.S. Bankruptcy Judge Henry Boroff denied GT's request to pay up to $25 million to critical vendors.

Boroff said he didn't want any eligible vendors on the creditors' committee, where they would be able to exercise influence over payments. I am unable to make a sufficient determination without an analysis of, or some specific evidence as to the effect on the debtor if products or services are not made, the judge said.

The case is In re GT Advanced Technologies Inc., 14-11916, U.S. Bankruptcy Court, District of New Hampshire (Manchester).


UPDATE: Packaging (PKG) in Prelim Evaluation of MLP, Has Engaged Advisors (IP) (RKT) Oct 21, 2014 10:28AM

(Updated - October 21, 2014 10:28 AM EDT)

(Updated - October 21, 2014 10:25 AM EDT)

Shares of Packaging Corp (NYSE: PKG) and peers International Paper (NYSE: IP) and RockTenn (NYSE: RKT) gained Tuesday after Packaging Corp said on a conference call that it is evaluating an MLP and has engaged legal and financial advisors.


DuPont (DD) Issues Commentary on EC's Statement of Objections for HFO-1234yf Oct 21, 2014 10:26AM

Thierry F.J. Vanlancker, president, DuPont (NYSE: DD) Chemicals & Fluoroproducts, said the following about the European Commission's Statement of Objections:

"DuPont has complied at all times with applicable laws in its development and commercialization of HFO-1234yf, and we plan to defend vigorously against the Commission's allegations and preliminary conclusions. This is one step in a long process, and while it may take years to be resolved, we are confident that the Commission will ultimately conclude that actions taken by DuPont complied with applicable laws. We will fight this every step of the way, as it has no basis in law or fact.

"We are disappointed in the European Commission and in the process leading up to this point. DuPont and Honeywell developed HFO-1234yf jointly in response to the European Union's Mobile Air Conditioning (MAC) Directive. This regulation requires automakers to use a refrigerant with very low global warming potential (low-GWP) for vehicle air-conditioning systems. The regulatory timeframe was short considering the significant challenges of developing and commercializing a refrigerant that meets all the automotive industry's needs. This short timeframe was a primary reason for DuPont and Honeywell working jointly to develop HFO-1234yf.

"Without DuPont and Honeywell's joint development, HFO-1234yf would not have been successfully developed and brought to market, and there would today be no commercially available solution satisfying the MAC Directive's criteria. From the outset, the companies have marketed and sold the refrigerant separately and independently, as competitors in the marketplace. DuPont has invested heavily to develop jointly a solution that greatly reduces potential climate impact. We have endured a host of regulatory, technical and financial challenges to be able to proudly offer this product to our customers, and we are disappointed the Commission chose to file this Statement in the final days of this Commissioner's tenure, after having looked at these facts for multiple years. We will respond to the Statement and will work to ensure that the Commission understands the competitive landscape and the details of our competitive relationship with Honeywell.

"Regardless of the Statement, the EU MAC Directive remains in full force today, with all new vehicles required to use a refrigerant with a GWP of under 150 by January 2017. HFO-1234yf has a 99.9 percent lower GWP than the refrigerant it was designed to replace, and meets a range of critical performance, sustainability and safety needs. Other low-GWP refrigerants are available for use in complying with the MAC Directive, but most automakers have concluded that HFO-1234yf is the best option. Most of the world's major automakers have already started their commercial transition to HFO-1234yf, and all but one are working to adopt HFO-1234yf.

"DuPont remains committed to work with our customers to ensure we meet their demand needs as they prepare to comply with the MAC Directive and other global programs that are driving mobile air conditioning to low GWP options."

DuPont – one of the first companies to publicly establish environmental goals more than 20 years ago – has broadened its sustainability commitments beyond internal footprint reduction to include market-driven targets for both revenue and research and development investment. The goals are tied directly to business growth, specifically to the development of safer and environmentally improved new products for key global markets.


UPDATE: Packaging (PKG) in Prelim Evaluation of MLP, Has Engaged Advisors (IP) (RKT) Oct 21, 2014 10:28AM

(Updated - October 21, 2014 10:28 AM EDT)

(Updated - October 21, 2014 10:25 AM EDT)

Shares of Packaging Corp (NYSE: PKG) and peers International Paper (NYSE: IP) and RockTenn (NYSE: RKT) gained Tuesday after Packaging Corp said on a conference call that it is evaluating an MLP and has engaged legal and financial advisors.


Generex Biotech (GNBT) Unit Publishes White Paper Promoting Ii-Key in Ebola Vaccine Development Oct 21, 2014 09:31AM

Generex Biotechnology Corporation (OTCBB: GNBT) announced that its wholly owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has issued a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine.

Antigen Express has a proprietary technology platform focused on specific activation of critical components of the immune system. As purely synthetic means are employed, more rapid development of new vaccines, at a lower cost, and with fewer manufacturing obstacles than traditional vaccines, is possible. The Antigen Express vaccines can be generated quickly to meet the demands of new threats, with one of the most recent threats being the Ebola virus.

  • The severity of the recent Ebola outbreak and failure of the health care system to contain the infection rates in West Africa underscore the need for the development of an effective vaccine that can be readily deployed in the field.
  • A vaccine is needed to best protect the healthcare workers and volunteers caring for Ebola patients, who are at the highest risk of infection, especially those operating in underequipped field conditions.
  • Experimental studies with Ebola virus vaccines have highlighted the need for efficient CD4+ T cell responses during immunization to yield an effective vaccine.
  • The Antigen Express Ii-Key Hybrid technology specifically and efficiently activates CD4+ T cell responses and is capable of both stimulating efficient immune responses on its own as well as boosting the efficacy of other vaccines to generate more robust humoral and cellular immunity.
  • Ii-Key Hybrids have been shown to be safe, well-tolerated, and to generate the desired specific immune response in humans in Phase I and II cancer vaccine trials as well as in a Phase I trial of Ii-Key hybrid vaccines targeted to the H5N1 (avian) and H1N1 (swine) influenza strains.

The white paper, which can be viewed online at the Generex and Antigen Express websites, presents the advantages of Antigen Express technology in development of an Ebola vaccine. In particular, this is presented in the context of the specific immunopathology of Ebola virus infection and its ability to resist the immune system. The specific advantages of Antigen Express technology for development of a protective Ebola virus vaccine for use in third world countries where the virus is endemic as well as developed countries is presented.

Antigen Express has an active partnering program for its lead products in breast and prostate cancer. It is also seeking strategic partners for its rapid vaccine development platform.


More Corporate News

View Older Stories

Oct 21, 2014 09:20AM Medtronic (MDT) Launches DIVERGENCE Anterior Cervical Fusion System in U.S.
Oct 21, 2014 09:18AM Gevo (GEVO) Reports Selling Isooctane to Total for Racing Fuel
Oct 21, 2014 09:16AM CEL-SCI Corp (CVM) Prices $6M Common, Warrants Offering at 76c Apiece
Oct 21, 2014 09:08AM On Track Innovations (OTIV) and USA Technologies (USAT) Report Being Ready for Apple Pay
Oct 21, 2014 08:59AM Staples (SPLS) on Watch After Reporting Possible Credit Card Breach
Oct 21, 2014 08:58AM Staples (SPLS) Active on Reports of Credit Card Data Breach; Says Working to Resolve Issue
Oct 21, 2014 08:54AM Tonix Pharmaceuticals (TNXP) Receives IND Clearance for TNX-201
Oct 21, 2014 08:35AM General Mills (GIS) Completes $46/Share Acquisition of Annie's
Oct 21, 2014 08:33AM Lilly & Co. (LLY) Reports FDA Acceptance of Empagliflozin + Metformin NDA
Oct 21, 2014 08:32AM Agios Pharma (AGIO) Initiates AG-221 Phase 1/2 in Advanced Solid Tumors
Oct 21, 2014 08:31AM LiveDeal (LIVE) CEO Isaac Plans Purchase of Up to 250K Shares
Oct 21, 2014 08:25AM Ford Motor (F) to Terminate Conversion Rights on 4.25% Senior Convertible Notes
Oct 21, 2014 08:22AM inVentiv Health to Replace eTMF CMS with Veeva Systems' (VEEV) Vault eTMF
Oct 21, 2014 08:15AM Pluristem Therapeutics (PSTI) Will Begin Manufacturing of Second Major Product Line, PLX-RAD
Oct 21, 2014 08:13AM Atlantic Power (AT) Issues Commentary on Clinton Group Letter; Expects to Remain Independent at This Time
Oct 21, 2014 08:11AM Clean Diesel Technologies (CDTI) Sells Reno-Based Exhaust, Parts Business; Prelim. Q3 Revs Miss Views
Oct 21, 2014 08:02AM Neonode (NEON) Announces Agreement with Tier One Printer OEM
Oct 21, 2014 07:37AM Coca Cola (KO) Updates on Key Growth Initiatives; Will Miss FY14 L-T EPS Growth Target
Oct 21, 2014 07:16AM Salix Pharma (SLXP) to Present Data from Rifaximin 550 mg Phase 3 as IBS-D Treatment
Oct 21, 2014 07:05AM Omeros Corp. (OMER) Suspends Huntington's Trial of OMS824
Oct 21, 2014 06:54AM Synergy Pharma (SGYP) Presents Statistically Significant Plecanatide Phase 2b Data in IBS-C
Oct 21, 2014 06:48AM Inovio Pharma (INO), Univ. of Penn, MedImmune (AZN) Awarded $12.2M DARPA Contract
Oct 21, 2014 06:34AM WHO Says NewLink's (NLNK) Experimental Ebola Vaccine Will Arrive in Geneva Today
Oct 21, 2014 06:09AM Tesla (TSLA) Will Report Q3 Results on Nov. 5th; Street Sees Revenue Doubling
Oct 20, 2014 05:34PM AbbVie (ABBV) Raises Dividend 17%, Reports $5B Buyback
Oct 20, 2014 05:32PM Auxilium Pharma (AUXL) XIAFLEX sBLA Gets FDA Approval
Oct 20, 2014 05:21PM Gold Resource (GORO) Reports Q3 Production of 17.2K Ounces
Oct 20, 2014 05:14PM AbbVie (ABBV), Shire (SHPG) Terminate Merger Talks
Oct 20, 2014 05:00PM Resolute Energy (REN) Updates on Q3 Operations, Horizontal Well Results
Oct 20, 2014 04:56PM Enanta Pharma (ENTA) Will Not Exercise co-Development Option on ABT-493
Oct 20, 2014 04:43PM Lam Research (LRCX) Reaches 100th Shipment Milestone for Syndion Module
Oct 20, 2014 04:29PM Hannon Armstrong (HASI) Makes $144M Investment in JP Morgan-Associated Wind Portfolio
Oct 20, 2014 04:28PM General American Investors (GAM) Reports NAV of $43.30 at End of Q314
Oct 20, 2014 04:20PM Allegheny Technologies (ATI) Enters Extended, Expanded LTAs with Major Jet Engine OEM
Oct 20, 2014 04:17PM Allegheny Technologies (ATI) Enters Titanium Investment Cast Product Supply Agreement with Snecma
Oct 20, 2014 04:13PM Medical Properties Trust (MPW) Enters $900M Acquisition, Lease Back Deal with MEDIAN Kliniken Group
Oct 20, 2014 04:12PM EV Energy Partners, L.P. (EVEP) Closes Sale of Cardinal Gas Services Stake
Oct 20, 2014 04:09PM Neurocrine Biosciences (NBIX) Begins Phase 3 Trial of NBI-98854
Oct 20, 2014 04:08PM Trinity Industries (TRN) Affirms Outcome of False Claims Act Case
Oct 20, 2014 04:01PM Starwood Hotels & Resorts (HOT) Sells The St. Regis, Rome in $150.7M Deal
Oct 20, 2014 03:59PM AT&T Inc (T) Will Carry Apple's (AAPL) iPad Air 2, iPad mini 3
Oct 20, 2014 03:38PM Constellation Brands (STZ) Launches 'Nourishing Neighbors' Campaign
Oct 20, 2014 03:27PM UPDATE: Trinity Industries (TRN) Active; Loses Trial Over $1B Highway Guardrail Lawsuit, Says Bloomberg
Oct 20, 2014 03:27PM UPDATE: Trinity Industries (TRN) Active; Loses Trial Over $1B Highway Guardrail Lawsuit, Says Bloomberg
Oct 20, 2014 03:20PM Microsoft (MSFT) Debuts Cloud Platform System, New Azure Marketplace
Oct 20, 2014 03:06PM Novartis (NVS) Reports FDA Committee Unanimously Recommends Approval of AIN457 in Plaque Psoriasis
Oct 20, 2014 01:46PM Vringo (VRNG) Reports Court of Appeals Invites Google to Respond to En Banc Petition
Oct 20, 2014 12:01PM Dassault to Offer Solution Utilizing Gogo Business Aviation (GOGO) Systems
Oct 20, 2014 11:14AM CBS Outdoor Americas (CBSO) Will Rebrand as 'Outfront Media'
View Older Stories